Please login to the form below

Not currently logged in
Email:
Password:

Takeda UK adds to its senior leadership team

Simon Meadowcroft and Pauline Bromley join the firm 

Takeda UKTakeda UK has added new names to its senior team with the appointment of a new medical director and human resources director.

Simon Meadowcroft joins as medical director, having held senior positions at Novartis and GSK, working with stakeholders to develop and drive strategy for key assets in their oncology portfolios.

Pauline Bromley also takes up the new position of human resources director and has over 15 years of experience working with small and large pharmaceutical organisations. She joins from LEO Pharma where she established professional and commercial HR practices to support a culture encouraging improved performance.

Adam Zaeske, managing director of Takeda UK, said: “We are working within a constantly changing healthcare environment and the medical function under the medical director's leadership will be crucial to ensure we align and work in partnership with the NHS as we bring important new medicines to market.

“Takeda is committed to advancing healthcare by developing specialist medicines that meet the needs of patients, healthcare professionals and society. Our focus on that goal means we need to ensure that our employees have the right skills and experience and are truly inspired to make a real difference.

“The recruitment of these two new senior roles will ensure that we are perfectly positioned to deliver on our aspirations.”

19th November 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics